TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria.

Esther K Schmitt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.